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An enormous amount of data has been generated in kidney
research using transcriptome analysis techniques. In this review
article, we first describe briefly the principles and major char-
acteristics of several of these techniques. We then summarize
the progress in kidney research that has been made by using
transcriptome analysis, emphasizing the experience gained and
the lessons learned. Several technical issues regarding DNA
microarray are highlighted because of the rapidly increased use
of this technology. It appears clear from this brief survey that
transcriptome analysis is an effective and important tool for
question-driven exploratory science. To further enhance the
power of this and other high throughput, as well as conven-
tional approaches, in future studies of the kidney, we propose
a multidimensional systems biology paradigm that integrates
investigation at multiple levels of biologic regulation toward
the goal of achieving a global understanding of physiology and
pathophysiology.
High throughput analysis of gene expression at the
mRNA level in a genome or near-genome scale (i.e.,
transcriptome analysis) has become one of the most
widely used approaches in the genomic era of biomed-
ical research. The development of these techniques, rep-
resented most prominently by DNA microarray, was
embraced with great excitement and with promises to
revolutionize biomedical research, including kidney re-
search. The rapidly increasing popularity of these tech-
niques is evidenced by more than 2000 PubMed entries
that contained the term “microarray” in the year 2003
alone, less than 10 years after the introduction of DNA
microarray techniques [1, 2].
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While an enormous amount of data has been gener-
ated using transcriptome analysis, how much this data
has meaningfully advanced our understanding of function
and disease remains an open question. It is worthwhile at
this time to reflect on the strengths and the weaknesses
of this approach and how it may be better utilized in fu-
ture studies. In this brief review article, we first describe
the technical principles and characteristics of major tech-
niques used for transcriptome analysis. We then summa-
rize the progress in kidney research that has been made
by using these techniques, emphasizing the experience
gained and the lessons learned. Several technical issues
regarding DNA microarray are highlighted. Finally, ways
in which these techniques can be better applied in future
studies are considered.
It appears clear from this brief survey that transcrip-
tome analysis is an effective and important tool for
question-driven exploratory science [3]. It is apparent,
however, these approaches will be more powerful when
they are appropriately integrated with proteomics, func-
tional measurement, and other approaches into a multi-
dimensional systems biology paradigm for the study of
physiology and pathophysiology.
TRANSCRIPTOME ANALYSIS: WHY?
Biologic function at any given moment is determined
by a myriad of factors such as ions, lipids, and cat-
alytic activity of enzymes, nearly all of which involve,
either directly or indirectly, the expression level of cer-
tain genes. Consequently, alterations of biologic func-
tion, especially sustained ones that occur in many dis-
eases, are often the result of changes in gene expression
levels.
In the simplified biologic axis of DNA-mRNA-protein
function, protein is the final product of gene expression
and the closest determinant of function. Intuitively, pro-
tein analysis would render measurement of mRNA (and
DNA for that matter) unnecessary. Moreover, it is known
that mRNA abundance does not always correspond to
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protein abundance [4–6], which suggests one should be
cautious when extrapolating mRNA to protein. It should
be noted that quantitative estimates of the extent of dis-
crepancy between mRNA and protein abundance based
on high-throughput assays should be interpreted cau-
tiously. This is because substantial noise exists in the mea-
surement at each level, particularly when the abundance
of mRNA and/or protein is low.
Even with some discrepancies between the abun-
dance of mRNA and protein, however, measurements of
mRNA are still very valuable for two major reasons. First,
current techniques for quantifying protein, compared to
mRNA, are more limited in throughput and possibly in
accuracy and sensitivity. In many cases, mRNA levels are
the best surrogates available for protein abundance. Sec-
ond, mRNA analysis could provide mechanistic insights
complementary to protein analysis, which can be signif-
icant not only scientifically, but also clinically. The clear
value of mRNA analysis, however, by no means implies
that mRNA measurement can replace protein measure-
ment. The issue of multilevel analysis will be discussed
later.
Techniques such as Northern blot, ribonuclease pro-
tection assay, and competitive reverse transcription-
polymerase chain reaction (RT-PCR) are very useful for
quantifying the mRNA expression levels of one or a few
genes at a time. The more challenging goals, however,
are to identify unsuspected changes in mRNA abundance
and to obtain a global view of biologic regulation likely
involving hundreds or more genes. Techniques allowing
high-throughput analysis of mRNA levels would obvi-
ously be more appropriate for achieving these goals.
TRANSCRIPTOME ANALYSIS: HOW?
Techniques for high-throughput analysis of mRNA lev-
els can be roughly divided into two categories based on
the outcome of the analysis: those yielding estimates of
absolute or relative levels of mRNA for all genes exam-
ined, and those primarily yielding the identity of a subset
of genes whose mRNA levels differ substantially between
the samples examined. DNA microarray, serial analysis
of gene expression (SAGE), high-throughput real-time
PCR, and sequencing of expressed sequence tags (EST)
belong to the first category. The second category mainly
includes mRNA differential display and subtractive
hybridization.
The basic technical principles for each of these tech-
niques are summarized in Figure 1. References contain-
ing extensive descriptions of these techniques, including
their important variants, are provided in the figure leg-
end.
The major technical advantages and disadvantages of
each of these techniques are listed in Table 1. Some of
these technical characteristics will be further discussed in
the context of application in kidney research.
APPLICATION IN KIDNEY RESEARCH
Cataloging renal transcripts
Generating a comprehensive catalog of the identities
and abundance of mRNA molecules is the most unique
utility of transcriptome analysis. SAGE is most appropri-
ate for generating such catalogs due to its quantitative
nature, potential comprehensiveness, and independence
of prior availability of sequence or cDNA clones. EST
sequencing and DNA microarray could also be used for
this purpose, although their ability to absolutely quantify
may be more limited. DNA microarray is further limited
by the prior availability of sequence or clones.
Several thousand distinct transcripts, including some
previously unknown sequences, have been identified in
mouse kidneys using SAGE [20, 21]. The most abundant
renal transcripts were found to be those related to mito-
chondrial metabolism and tubular transport and primar-
ily associated with the proximal tubule. The latter was
not surprising since proximal tubules constitute the ma-
jority of the kidney mass. mRNA species of lower levels
of abundance may not have been represented in these
mRNA catalogs.
To obtain transcript profiles in specific nephron seg-
ments, a SAGE method using a much smaller amount
of starting mRNA samples was developed and ap-
plied to mouse and human kidneys [21, 22]. Several
hundred transcripts were reported to be differentially
expressed among nephron segments. The grouping of
nephron segments based on the number of shared tran-
scripts appeared consistent with known functional simi-
larities among nephron segments. A 3′-cDNA sequencing
method has also been used to identify and quantify a few
thousand transcripts in the proximal tubule and the inner
medullary collecting duct [23, 24].
Baseline renal mRNA profiles in human and mouse
have also been assessed using DNA microarray [25–28].
Some of these studies emphasized the observation that
renal mRNA levels of many genes varied among “nor-
mal” individuals. This is consistent with the well-known
biologic variability among individuals. However, the re-
ported magnitude of such individual variability might
highly depend on how technical variability was assessed
and accounted for.
Identifying new regulatory mechanisms
The most common use of transcriptome analysis is to
discover new regulatory mechanisms. This is most often
achieved through comparing mRNA profiles between in-
terventions, disease states, or developmental stages to
identify differentially expressed genes.
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Table 1. Characteristics of major techniques for transcriptome analysis
Real-time Differential Subtractive
Microarray SAGE PCR display hybridization
Levels of Levels of EST Levels of Differentially Differentially
all genes all genes Mainly all genes expressed expressed
Output examined examined qualitative examined genes genes
Number of genes 10,000 s 10,000 s 10,000 s 10 s 10,000 s/10 s 10,000 s/10 s
Number of samples 10 s A few A few 100 s A few A few
False positive Y Y Y Y/N Y Y
False negative Y Y Y Y/N YY YY
Special equipment Arrayer laser DNA Large-capacity Real-time DNA DNA
scanner sequencer DNA sequencer PCR machine sequencer sequencer
Time Days >Weeks >Months Hours >Weeks >Weeks
Requiring prior clones/sequences Y N N Y N N
Abbreviations are: SAGE, serial analysis of gene expression; EST, expressed sequence tags, PCR, polymerase chain reaction; s, multiplicity.
Table 2. Examples of differential expression identified by transcriptome analysis and validated to be functionally relevant in the kidney
Genes Differential expression Discovery techniques Functional relevance References
CTGF Up-regulated by high glucose in
mesangial cells
SSH Extracellular matrix deposition
and cell hypertrophy
29–32
calcyclin Up-regulated by vasopressin in
cortical collecting duct cells
SSH Late-phase effects of vasopressin on
collecting duct ion transport
33
Stra13 Up-regulated by prostaglandin E2 in
podocytes
SSH Protection against oxidant-induced
injury
34
AngRem104 Up-regulated by angiotensin II in
mesangial cells
SSH Possibly stimulating fibronectin
synthesis
35, 36
Xanx-4 Expressed specifically in developing
pronephric tubules
Subtractive hybridization Development of pronephric tubules
in Xenopus laevis
37
sgk Up-regulated by aldosterone in
cortical collecting duct cells
SSH and differential display Stimulation of epithelial Na+
channels
38–43
thrombospondin-1 Up-regulated by high glucose in
mesangial cells
Differential display activation of TGF-b1 44, 45
Diphor-1 Up-regulated in renal cortex by
dietary phosphate
Differential display Stimulation of Na-Pi cotransport in
Xenopus oocytes
46
GZF1 Up-regulated in neuroblastoma cells
by GDNF
Differential display Required for renal branching
morphogenesis
47
Thiol genes Up-regulated by high glucose in
mesangial cells
DNA microarray Buffering oxidative stress 48
OSMRb Up-regulated by activated PBMC
conditioned medium in renal
epithelial cells
DNA microarray Epithelial cell-myofibroblast
transdifferentiation
49
Abbreviations are: CTGF, connective tissue growth factor; SSH, suppression subtractive hybridization; sgk, serum- and glucocorticoid-activated kinase; GDNF,
glial cell line-derived neurotrophic factor; GZF1, GDNF-inducible zinc finger gene 1; OSMRb , oncostatin M receptor b ; PBMC, peripheral blood mononuclear cells;
TGF-b1, transforming growth factor-b1.
One straightforward approach in this line of research
is to use transcriptome analysis as a crude screening tool
for selecting one or a few responsive genes. The bio-
chemical characteristics and functional relevance of these
genes are then investigated in detail using other methods,
including experimentally overexpressing or suppressing
these genes/gene products. Since the purpose of transcrip-
←−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Fig. 1. Principles of major techniques for transcriptome analysis. Basic principles of each technique are shown. A more detailed description of
each technique as well as its variants can be found in the references cited below. (A) DNA microarray. A typical scheme for two-color hybridiza-
tion of cDNA microarray [2, 7] is shown. For more information on cDNA microarray, see http://www.microarray.org and http://www.agilent.com.
Affymetrix oligonucleotide GeneChip is another widely used DNA microarray platform [1, 8]. For more information on Affymetrix GeneChip, see
http://www.affymetrix.com. For a collection of review articles on DNA microarray, see “Chipping Forecast and Chipping Forecast II,” Nature Genet-
ics 21 (Suppl) 1999, and 32 (Suppl) 2002. (B) Serial analysis of gene expression (SAGE) [9, 10]. For an online repository of microarray and SAGE
data, see http://www.ncbi.nlm.nih.gov/geo. (C) High-throughput real-time polymerase chain reaction (PCR) [11, 12]. (D) Sequencing of expressed
sequence tags (EST). Also see http://www.ncbi.nlm.nih.gov/UniGene/info ddd.shtml. (E) mRNA differential display [13–16]. (F) Suppression sub-
tractive hybridization (SSH) [17]. Abbreviationa are: RT, reverse transcription; ds, double-stranded. See [18, 19] for additional description of these
techniques in the context of kidney research.
tome analysis in this setting is crude screening, a lower
level of accuracy and comprehensiveness is often accept-
able. This approach has led to a number of novel findings
in kidney research, several examples of which are sum-
marized in Table 2. Some of these findings have opened
new areas of investigation, demonstrating the power of
high-throughput screening.
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Another approach utilizes transcriptome analysis as a
true profiling tool to obtain global views of regulatory
pathways and networks. This is an attractive goal and has
been claimed to be the purpose of many transcriptome
analysis studies, especially those using DNA microarray.
Several interesting assemblies of global regulatory net-
works have been reported in simpler model organisms
[5, 50–53]. However, conclusions from similar attempts
in complex mammalian organisms and organ systems, in-
cluding the kidney, largely remain unsubstantiated. This
is the result of a combination of factors, including the
limited accuracy of current analytical techniques, inher-
ent biologic complexity, and difficulty in validating global
networks of regulation even if one intends to do so. Some
of these obstacles can be overcome by taking a multi-
dimensional systems biology approach that will be dis-
cussed later.
Diagnosis and prognosis
Transcriptome analysis could potentially be used to
identify signature mRNA expression patterns that could
help to diagnose and to predict the future course of kid-
ney disease [54]. For example, mRNA expression patterns
specific to renal tumors, or certain subtypes of renal tu-
mors, have been reported in several studies [55–59]. Gene
expression patterns in renal allografts associated with fu-
ture development of chronic rejection [60], or indicative
of new subtypes of acute rejection [61], have been re-
ported. In addition, several genes were shown to be as-
sociated with renal mesangial matrix expansion in mouse
models of diabetes and, therefore, may be predictive of
the development of diabetic nephropathy [62]. The ap-
plicability of the above markers to a larger number of
patients and the value of these markers beyond conven-
tional diagnostic and prognostic techniques requires fur-
ther examination.
Technical considerations for DNA microarray studies
It is clear from Table 1 that DNA microarray has some
potential advantages over other techniques. The major
advantage is the combination of quantifiability, compre-
hensiveness, speed, and relative ease of use. Therefore,
it is not surprising that DNA microarray, despite being
a relatively new technique for transcriptome analysis, is
rapidly gaining popularity. DNA microarray has been
used, mostly within the last 3 years, to study numerous
aspects of kidney biology and disease, including physiol-
ogy [63–77], development [78–81], acute injury [82–95],
chronic dysfunction [62, 96–107], hypertension [108–116],
transplantation [60, 61, 117–119], and tumors [120–124].
Many of these studies reported dozens or hundreds of
genes being differentially expressed between the treated
or diseased samples and the control samples.
With such a huge amount of data being generated, a
major concern is that the new biological insights that
have been revealed by this data, and validated by ad-
ditional studies have been limited. This is particularly
true when one attempts to derive global regulatory net-
works from these data (see above). On the other hand,
one could argue that since DNA microarray is mainly a
hypothesis-generating tool, many new insights may not be
immediately apparent, and could require years of follow-
up investigation to be illuminated. This argument is valid
only if the microarray data are reliable. In this regard,
a microarray study is just like any other biologic ex-
periments: it requires a rational experimental design,
extensive optimization of experimental and analytic tech-
niques, critical interpretation, and logical follow-up. Ta-
ble 3 lists a number of general considerations that, based
on the literature and the authors’ experience, could help
to enhance the reliability of microarray data and the rel-
evance of a microarray study.
Toward systems biology
There is no doubt that transcriptome analysis will
continue to be an important tool for question-driven
exploratory science. Refinements and modifications
of techniques such as DNA microarray are continu-
ously being introduced [125–132]. The application of
transcriptome analysis, including that in kidney research,
will continue to expand as the measurement becomes
more accurate and affordable.
However, in contrast to some early expectations, it is
also clear that transcriptome analysis alone will not be
sufficient for characterizing complex networks of bio-
logical regulation in human and mammalian model an-
imals. It is unlikely in the foreseeable future that these
techniques will allow comprehensive and perfectly accu-
rate measurement of mRNA abundance. Measurements
of proteins and other metabolites can complement the
mRNA analysis or provide, in a sense, a validation of
some mRNA data. More important, steady-state mRNA
abundance is not the only level at which biological func-
tion is regulated. Genetic materials, protein characteris-
tics (abundance, location, modification, and interaction),
and small molecules can be equally or more important
levels at which biological function is regulated. Fortu-
nately, techniques allowing high-throughput analysis of
DNA, protein, and even function [133] have been or are
being actively developed and applied in kidney research.
Particularly, recent advances in proteomics techniques
that allow high-throughput analysis of protein character-
istics are being incorporated into kidney research [134].
For instance, improvements have been made in meth-
ods for labeling or capturing proteins, mass spectrometry
technology, and protein or antibody microarrays, all of
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Table 3. General considerations in transcriptome analysis using DNA microarray
Stage of a DNA microarray study General considerations
Selecting an array platform Affymetrix GeneChip: Enhanced specificity provided by including mismatched probes
cDNA microarray: Allowing within-array comparison of two or more samples
Experimental design Including sufficient replicates and dye swaps (for two-color hybridization)
Pairing samples involved in the most interesting comparisons (for two-color hybridization)
Sample preparation and array hybridization Good quality of arrays and mRNA samples
Critically evaluating, in your own lab, the fidelity of any amplification methods
Data analysis and interpretation Filtering off low-quality, misleading data points
Using statistical tests that take variance and multiple comparisons into consideration
Considering biologic complexity (redundancy, adaptation, etc.)
Validation of differential expression Including new samples not used in the array experiment if possible
Measuring protein and other downstream biochemical changes if possible
Investigation of biological relevance Mutants, antagonists, or agonists can be used, but new reagents (expression constructs,
antisense oligonucleotides, small interfering RNA, etc.) often need to be developed
Vasculature
Tubule
Interstitium
Kidney
Whole body
Other organ
systems
Integrative,
multidimensional
understanding of
physiology and
pathophysiology
High-throughput,
question-driven
research:
genomics, proteomics,
metabolomics,
functional analysis
Conventional
hypothesis-driven
research
Fig. 2. A systems biology approach to kid-
ney research. Question-driven exploratory re-
search can integrate fragmental knowledge
into broader perspectives and discover novel
directions for conventional, reductionism re-
search. Hypothesis-driven research is often
needed for validating new mechanisms sug-
gested by exploratory research and can pro-
vide rationales for prioritizing costly high-
throughput analyses. A combination of these
approaches should be more efficient than each
approach alone for obtaining an integrative
understanding of renal physiology and patho-
physiology.
which may contribute to enhancing the throughput level,
accuracy, and sensitivity of protein analysis.
To provide a theoretic framework within which infor-
mation of global biological regulation can be integrated
and understood, we have proposed a multidimensional
systems biology paradigm for biomedical research [3].
At its core, systems biology represents a renewed recog-
nition that biology is best understood by taking a coor-
dinated, integrative systems view [135]. In practice, this
multidimensional systems biology paradigm consists of
comprehensive analysis of DNA, RNA, protein, small
molecules and ions, as well as cellular and organ sys-
tem functions. Information generated at these comple-
mentary levels of biologic regulation are then integrated,
often through the use of computational biology, includ-
ing mathematical modeling, at each level, across all lev-
els, and across several biologic states to provide a global
view of biologic regulation. It is clearly a formidable task
to achieve such an integrative understanding of mam-
malian physiology and pathophysiology. Current high-
throughput assays require substantial improvement, par-
ticularly in accuracy. It can be an even greater challenge
to integrate data obtained from various global analyses
and reductionism approaches. While algorithms for im-
plementing multidimensional systems biology are in their
infancy, the readers are referred to a previous perspec-
tives article [3] for several examples of the initial applica-
tion of this research paradigm in several model organisms.
This multidimensional systems biology approach to
biomedical research is not entirely new as a concept. Var-
ious aspects of this approach have been emphasized for
decades, especially by medical scientists and integrative
physiologists. The significance of solidifying and reem-
phasizing such an approach lies largely in the fact that
recent developments of several high-throughput analyti-
cal techniques, such as transcriptome analysis, have made
this approach more feasible than ever.
Figure 2 depicts how the multidimensional systems bi-
ology approach can be applied to the study of the kidney.
The kidney presents a significant challenge for the appli-
cation of the systems biology approach, mainly because
it is structurally and functionally highly heterogeneous
and compartmentalized. Because of this complexity, how-
ever, the systems biology approach may be the only way
to achieve a truly complete understanding of the kidney.
Indeed, renal physiology is one of few areas where certain
key components of systems biology, such as mathematical
modeling, have already been an important driving force
for the generation of new knowledge.
The lessons learned from transcriptome analysis
demonstrate, once again, that limitations are inevitable
even in the most powerful approaches. On the other hand,
the success in the application of transcriptome analysis in
the study of the kidney, although still limited at this time,
strongly encourages the adoption of the systems biology
approach into kidney research.
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